ArticleJournal of cancer research and clinical oncology2024

Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase.

JingCheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.